Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
62°
Sunny
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Illumina, Inc. - Common Stock
(NQ:
ILMN
)
85.60
+1.55 (+1.84%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 14, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Illumina, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
20
21
Next >
Jim Cramer Says Illumina Is 'Challenged,' Recommends Selling This Industrial Stock
Today 8:22 EDT
Cramer looks at Illumina, Archer Aviation, NANO Nuclear Energy, Steris, Sixth Street Specialty Lending, Lam Research and Arista Networks.
Via
Benzinga
Nvidia Stock Reached All-Time Highs After Jensen Huang's CES Keynote — Will Next Week's GTC Spark Another Surge?
March 13, 2025
Jensen Huang will give a keynote speech at Nvidia's GTC conference next week. A keynote from Huang at CES earlier this year took Nvidia stock to highs.
Via
Benzinga
Tesla To $120? Here Are 10 Top Analyst Forecasts For Wednesday
March 12, 2025
Via
Benzinga
Demystifying Illumina: Insights From 11 Analyst Reviews
March 05, 2025
Via
Benzinga
Here's How Much $1000 Invested In Illumina 20 Years Ago Would Be Worth Today
March 03, 2025
Via
Benzinga
$1000 Invested In Illumina 20 Years Ago Would Be Worth This Much Today
February 25, 2025
Via
Benzinga
Goldman Sachs Gains Confidence In Market Rebound, Upgrades GE Healthcare Amid China Recovery Hopes
March 11, 2025
Goldman Sachs upgrades GE Healthcare to Buy, raising its price target to $100, as analysts see market stabilization and China sales recovering faster than expected.
Via
Benzinga
Diagnostic Kit Maker Illumina To Cut $100 Million In Costs, Lowers 2025 Profit Outlook Amid China Trade Restrictions
March 11, 2025
Illumina slashes costs by $100 million after China bans its sequencers. The company lowers its 2025 EPS outlook and aims for high-single-digit growth by 2027.
Via
Benzinga
3 Reasons to Sell ILMN and 1 Stock to Buy Instead
March 07, 2025
What a brutal six months it’s been for Illumina. The stock has dropped 30.9% and now trades at $84.65, rattling many shareholders. This may have investors wondering how to approach the situation.
Via
StockStory
Illumina Stock Slammed As China Retaliates Against Trump's Tariffs
March 04, 2025
The company's gene-mapping products are now banned from import in China amid the escalating trade war between the U.S. and China.
Via
Investor's Business Daily
Topics
Government
World Trade
Exposures
Political
Tariff
US Firm Illumina Faces Setback as China Blocks Imports Amid Escalating Trade War
March 04, 2025
China banned imports of Illumina's gene sequencers as new U.S. tariffs took effect, cutting its market access while Chinese rivals gain ground in the biotech sector.
Via
Benzinga
Topics
World Trade
Exposures
Tariff
Why Illumina Stock Got Mashed on Monday
February 10, 2025
Via
The Motley Fool
The Analyst Verdict: Illumina In The Eyes Of 7 Experts
February 10, 2025
Via
Benzinga
Why Illumina Stock Is Sinking Today
February 07, 2025
Via
The Motley Fool
Biotech Stocks Had A Good Week Despite Crosscurrents
February 18, 2025
It’s too early to account for the rally but in general one can say that there is a lot of speculation from both the retail side and hedge funds.
Via
Talk Markets
Topics
ETFs
Stocks / Equities
Wall Street's Top 10 Stock Calls This Week - Saturday, Feb. 15
February 15, 2025
What has Wall Street been buzzing about this week? Here is a look at the top 5 buy calls and the top 5 sell calls made by Wall Street's best analysts during the trading week of Feb. 10-14, 2025.
Via
Talk Markets
Topics
Stocks / Equities
PacBio (PACB) Q4 Earnings Report Preview: What To Look For
February 12, 2025
Genomics company Pacific Biosciences of California (NASDAQ:PACB) will be announcing earnings results tomorrow after market hours. Here’s what investors should know.
Via
StockStory
10x Genomics (TXG) Reports Earnings Tomorrow: What To Expect
February 11, 2025
Biotech company 10x Genomics (NASDAQ:TXG) will be reporting earnings tomorrow after market hours. Here’s what to look for.
Via
StockStory
Cathie Wood Dumps $16 Million Worth Of Palantir Stock After Record Highs
February 10, 2025
On Monday, February 10, 2025, the Cathie Wood-led Ark Invest sold nearly $16 million worth of Palantir shares amid a spike in the share price of the company.
Via
Benzinga
Illumina Analysts Slash Their Forecasts Following Q4 Results
February 07, 2025
Via
Benzinga
Illumina Earnings Report: Q4 Overview
February 06, 2025
Via
Benzinga
Why Illumina (ILMN) Stock Is Trading Lower Today
February 10, 2025
Shares of genomics company Illumina (NASDAQ:ILMN) fell 7.5% in the morning session after Barclays downgraded the stock to Sell and lowered the price target from $130 to $100. The firm cited several...
Via
StockStory
This Illumina Analyst Turns Bearish; Here Are Top 5 Downgrades For Monday
February 10, 2025
Via
Benzinga
Estee Lauder, Moderna And PayPal Are Among Top 10 Large Cap Losers Last Week (Feb 3-Feb 7): Are The Others In Your Portfolio?
February 09, 2025
Skyworks Solutions, Estee Lauder, Venture Global, Neurocrine Biosciences, Moderna, Illumina, IDEX Corporation, PTC Inc, PayPal Holdings, Skechers U.S.A. and Avantor were worst performers, fell up to...
Via
Benzinga
Cathie Wood's Ark Invest Bets Big On Amazon, Roblox And Illumina While Trimming Palantir Stake After Alex Karp-Led Company Touched An All-Time High On Thursday
February 08, 2025
Ark Invest made significant trades on Friday, including buying Amazon and Roblox stock and selling Palantir stock. Other key trades were also made.
Via
Benzinga
Why Illumina (ILMN) Stock Is Falling Today
February 07, 2025
Shares of genomics company Illumina (NASDAQ:ILMN) fell 8.6% in the morning session after the company reported fourth-quarter results and provided full-year revenue guidance, which fell below Wall...
Via
StockStory
Amazon To Rally Over 20%? Here Are 10 Top Analyst Forecasts For Friday
February 07, 2025
Via
Benzinga
Skechers Posts Downbeat Results, Joins e.l.f. Beauty, LiveRamp And Other Big Stocks Moving Lower In Friday's Pre-Market Session
February 07, 2025
Via
Benzinga
Illumina (NASDAQ:ILMN) Beats Q4 Sales Targets
February 06, 2025
Genomics company Illumina (NASDAQ:ILMN) reported Q4 CY2024 results exceeding the market’s revenue expectations, but sales were flat year on year at $1.1 billion. On the other hand, the company’s...
Via
StockStory
Wall Street Drops On Tariffs Threat, Dollar Rises, Uber Rockets On Ackman's Tweet: What's Driving Markets Friday?
February 07, 2025
Wall Street slumped into negative territory late in the week as renewed fears over inflation and trade tariffs eroded risk appetite.
Via
Benzinga
Topics
Economy
World Trade
Exposures
Interest Rates
Tariff
< Previous
1
2
3
4
5
6
7
8
9
...
20
21
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.